Puma Biotechnology Inc Price to Earnings Ratio (PE) Ratios, (PBYI) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Puma Biotechnology Inc   (NASDAQ: PBYI)
 





PBYI Price to Earnings Ratio Current (Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Diluted EPS 12 Trailing Months IV. Quarter III. Quarter II. Quarter I. Quarter
PE (TTM) Ratio current            18.88            9.14            6.59            3.43            3.98
Diluted EPS TTM Y / Y Change -36.36 % 1.64 % 54.17 % 415.79 % 133.33 %
Diluted EPS Y / Y Change - % -30.77 % -58.54 % - % - %
Stock performance to date 35.63 % 28.57 % 66.12 % 0.97 % 13.98 %

Price to earnings ratio Comment
Puma Biotechnology Inc 's current Price to earnings ratio has increased due to shareprice growth of 35.63 %, from beginning of I. Quarter and due to eps contraction of 0 %, to Pe of 18.88, from average Price to earnings ratio in IV. Quarter of 9.14.

Within Healthcare sector 109 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Puma Biotechnology Inc Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #60
Sector #110
S&P 500 #1283





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.